Literature DB >> 11673517

Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system.

B Bonnotte1, N Larmonier, N Favre, A Fromentin, M Moutet, M Martin, S Gurbuxani, E Solary, B Chauffert, F Martin.   

Abstract

Immunization can prevent tumor growth, but the effector cells directly responsible for tumor cell killing in immunized hosts remain undetermined. The present study compares tumor grafts that progress in naive syngeneic rats with the same grafts that completely regress in hosts preimmunized with an immunogenic cell variant. The progressive tumors contain only a few macrophages that remain at the periphery of the tumor without direct contact with the cancer cells. These macrophages do not kill tumor cells in vitro. In contrast, tumors grafted in immunized hosts and examined at the beginning of tumor regression show a dramatic infiltration with mature macrophages, many of them in direct contact with the cancer cells. These macrophages are strongly cytotoxic for the tumor cells in vitro. In contrast to macrophages, tumor-associated lymphocytes are not directly cytotoxic to the tumor cells, even when obtained from tumor-immune rats. However, CD4(+) and CD8(+) T cells prepared from the regressing tumors induce tumoricidal activity in splenic macrophages from normal or tumor-bearing rats and in macrophages that infiltrate progressive tumors. These results strongly suggest that the main tumoricidal effector cells in preimmunized rats are macrophages that have been activated by adjacent tumor-immune lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673517     DOI: 10.4049/jimmunol.167.9.5077

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanism.

Authors:  Collin J LaCasse; Nona Janikashvili; Claire B Larmonier; Darya Alizadeh; Neale Hanke; Jessica Kartchner; Elaine Situ; Sara Centuori; Michael Har-Noy; Bernard Bonnotte; Emmanuel Katsanis; Nicolas Larmonier
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

2.  Signaling pathways induced by a tumor-derived vaccine in antigen presenting cells.

Authors:  Jessica Cantrell; Claire Larmonier; Nona Janikashvili; Sara Bustamante; Jennifer Fraszczak; Amanda Herrell; Tamara Lundeen; Collin J LaCasse; Elaine Situ; Nicolas Larmonier; Emmanuel Katsanis
Journal:  Immunobiology       Date:  2009-10-31       Impact factor: 3.144

3.  Effect of bone marrow-derived monocytes transfected with RNA of mouse colon carcinoma on specific antitumor immunity.

Authors:  Xiao-Yuan Chu; Long-Bang Chen; Jing Zang; Jing-Hua Wang; Qun Zhang; Huai-Cheng Geng
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

4.  Active Microneedle Administration of Plant Virus Nanoparticles for Cancer in situ Vaccination Improves Immunotherapeutic Efficacy.

Authors:  Christine E Boone; Chao Wang; Miguel Angel Lopez-Ramirez; Veronique Beiss; Sourabh Shukla; Paul L Chariou; Daniel Kupor; Ricardo Rueda; Joseph Wang; Nicole F Steinmetz
Journal:  ACS Appl Nano Mater       Date:  2020-08-07

5.  Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma.

Authors:  Aurélie Collignon; Françoise Silvy; Stéphane Robert; Malika Trad; Sébastien Germain; Jérémy Nigri; Frédéric André; Véronique Rigot; Richard Tomasini; Bernard Bonnotte; Dominique Lombardo; Eric Mas; Evelyne Beraud
Journal:  Oncoimmunology       Date:  2018-09-25       Impact factor: 8.110

6.  Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors.

Authors:  Terry G Coursey; Peter W Chen; Jerry Y Niederkorn
Journal:  Cancer Res       Date:  2011-02-09       Impact factor: 12.701

7.  Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins.

Authors:  Daniela Taverna; Heather Moher; Denise Crowley; Lubor Borsig; Ajit Varki; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

8.  CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer.

Authors:  Stephan Roux; Lionel Apetoh; Fanny Chalmin; Sylvain Ladoire; Grégoire Mignot; Pierre-Emmanuel Puig; Gregoire Lauvau; Laurence Zitvogel; François Martin; Bruno Chauffert; Hideo Yagita; Eric Solary; François Ghiringhelli
Journal:  J Clin Invest       Date:  2008-10-01       Impact factor: 14.808

9.  Roles of Eicosanoids in Regulating Inflammation and Neutrophil Migration as an Innate Host Response to Bacterial Infections.

Authors:  Austin E F Sheppe; Mariola J Edelmann
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

10.  Green Propolis Compounds (Baccarin and p-Coumaric Acid) Show Beneficial Effects in Mice for Melanoma Induced by B16f10.

Authors:  Gabriel H Gastaldello; Ana Caroline V Cazeloto; Juliana C Ferreira; Débora Munhoz Rodrigues; Jairo Kennup Bastos; Vanessa L Campo; Karina F Zoccal; Cristiane Tefé-Silva
Journal:  Medicines (Basel)       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.